2nd Quarter - Amendment

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$333,296
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medicare Physician Payments Reform, Patient access to care; Graduate Medical Education; Physician Workforce Issues; Health reform implementation (PL 111-148); Telehealth (Health Information Technology)

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); White House Office; SENATE; Office of Management & Budget (OMB); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC)

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); White House Office; Centers For Disease Control & Prevention (CDC); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA)

Taxation/Internal Revenue Code TAX

Flexible Spending Accounts; Health Savings Accounts

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); White House Office

Medicare/Medicaid MMM

Graduate Medical Education; Health Care Quality, Patient Access to Health Care; Physician Workforce; Medicare Physician Payment Issues; Independent Payment Advisory Board. H.R. 574, The Medicare Physician Payment Innovation Act of 2013.

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: SENATE; Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); White House Office; Food & Drug Administration (FDA); Government Accountability Office (GAO); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS)

Bills named: H.R. 574 (114th)

Budget/Appropriations BUD

Labor HHS Appropriations

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); SENATE; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Executive Office of the President (EOP); White House Office

Insurance INS

Health Insurance; Professional Liability Insurance; State Insurance Marketplace

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA)

Education EDU

Student Loan Financing and Re-Financing

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Executive Office of the President (EOP); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); SENATE; HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); White House Office

Medical/Disease Research/Clinical Labs MED

NIH; FDA; Agency for Health Care Quality & Research Funding

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); White House Office; Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE

Torts TOR

Professional Liability Insurance; Medical Liability Reform

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); SENATE; Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.